"The Future of the Alopecia Market: Trends Reshaping the Industry"

Comments · 4 Views

The global Alopecia market size was valued at USD 8,869.23 Million in 2022 and is projected to reach from USD XX Million in 2023 to USD 17,582.12 Million in 2031, growing at a CAGR of 7.9% during the forecast period (2023–2031).

 
 

Alopecia Market Analysis, Size, Share, Growth, Trends, and Forecast

 
 
 
Straits Research has published its latest report, titled "Alopecia Market: Information by Disease Type (Alopecia Areata, Cicatricial Alopecia, Traction Alopecia, Alopecia Totalis, Alopecia Universalis, Androgenetic Alopecia, Others), by Treatment (Pharmaceuticals, Devices), by Gender (Males, Females), by Sales Channels (Prescription, OTC), and by End-User (Homecare Settings, Dermatology Clinics) - Global Forecast to 2031." The comprehensive study provides an in-depth analysis of the global Alopecia market, highlighting key drivers, trends, and opportunities.

Market Overview

The global Alopecia market size was valued at USD 8,869.23 Million in 2022 and is projected to reach from USD XX Million in 2023 to USD 17,582.12 Million in 2031, growing at a CAGR of 7.9% during the forecast period (2023–2031).
 
 

Drivers in the Alopecia Market

The increasing prevalence of alopecia worldwide, coupled with growing awareness and acceptance of treatments, is driving the growth of the market. Additionally, advancements in technology and the development of novel treatments, such as low-level laser therapy (LLLT) and platelet-rich plasma (PRP) therapy, are expected to fuel market growth.

Key Developments in the Alopecia Market

  • In 2022, Pfizer Inc. announced the FDA approval of its oral JAK inhibitor, ritlecitinib, for the treatment of alopecia areata.
  • In 2023, Cipla Inc. launched its generic version of minoxidil, a topical treatment for androgenetic alopecia.

Top Key Players

The global Alopecia market is highly competitive, with several key players operating in the space. Some of the top key players include:
  • Pfizer Inc.
  • Cipla Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Johnson & Johnson Service Inc.
  • Merck & Co. Inc.
  • GlaxoSmithKline plc
  • Dr. Reddy's Laboratories Ltd.
  • Mylan N.V.
  • Curallux LLC.
  • LUTRONIC
  • iRestore Hair Growth System (Freedom Laser Therapy)
  • Lexington Intl. LLC.
  • iGrow Laser (Apira Science Inc)
  • REVIAN Inc.
  • Theradome.

Segmentation Analysis of the Alopecia Market:

The global Alopecia market can be segmented based on disease type, treatment, gender, sales channels, and end-user.

By Disease Type

  • Alopecia Areata
  • Cicatricial Alopecia
  • Traction Alopecia
  • Alopecia Totalis
  • Alopecia Universalis
  • Androgenetic Alopecia
  • Others

By Treatment

  • Pharmaceuticals
  • Devices

By Gender

  • Males
  • Females

By Sales Channels

  • Prescription
  • OTC

By End-User

  • Homecare Settings
  • Dermatology Clinics

 

This Report is available for purchase on @https://straitsresearch.com/buy-now/alopecia-market

Company Details:

Straits Research is a top provider of business intelligence, specializing in research, analytics, and advisory services, with a focus on delivering in-depth insights through comprehensive reports.

Contact Us:

Email: sales@straitsresearch.com
Address: 825 3rd Avenue, New York, NY, USA, 10022
Phone: +1 646 905 0080 (US), +91 8087085354 (India), +44 203 695 0070 (UK)
Comments